Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Barron Von Hymen who wrote (2610)	5/19/1998 4:29:00 PM
From: BigKNY3	Read Replies (1) \| Respond to of 9523

From Mommailion on AOL's Motley Fool PFE Board: BigKNY3 Viagra is the scheduled topic for Oprah's show tomorrow, May 20th. This per online Oprah schedule (keyword: Oprah). Here's the description posted for the show: "Viagra Tales (PG) Recently, the FDA approved Viagra, the first pill to treat impotence. This dysfunction affects millions of men in the United States, and the demand and popularity of Viagra has made headline news for weeks. Today we'll hear from men -- and women -- who've tried this so-called "miracle drug." They'll tell you if it worked for them. We'll also get important information from doctors who will share their medical opinions about the safety and effectiveness of this new remedy."

To: Barron Von Hymen who wrote (2610)	5/20/1998 9:07:00 AM
From: MARIO PASQUA	Respond to of 9523

ANY GUESS FOR YEAR END 1998 (millions of dollars) 1997 PFIZER BEFORE VIAGRA Net sales $12,188 Alliance revenue $ 316 Total revenues $12,504 Cost of sales $ 2,274 % of total revenues 18.2% Selling, informational and administrative expenses $ 4,956 % of total revenues 39.6% R&D expenses $ 1,928 % of total revenues 15.4% Other deductions--net $ 258 % of total revenues 2.1% ---------------------------------------------------------- Income before taxes $ 3,088 % of total revenues 24.7% Taxes on income $ 865 Effective tax rate 28.0% Income from continuing operations $ 2,213 % of total revenues 17.7% Net income $ 2,213 % of total revenues 17.7%